Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 195 results found. Search for [ coronavirus antibodies ]

Results 1 to 21 of 195
BusinessToday.In
November 19, 2020
Late-stage trials of the Oxford vaccine are still awaited but hopes are high that it'll also join frontrunners' league with Pfizer, Moderna and Russia's Sputnik V


Manali
November 19, 2020
Barclays is upbeat about an economic revival in the economy from FY22 and has also raised its (FY22) GDP growth forecast to 8.5% from 7.0% earlier, to reflect a faster recovery in services amid continued policy support


Reuters
November 18, 2020
The Sinovac findings, published in a peer-reviewed paper in medical journal The Lancet Infectious Diseases, came from results in Phase I and Phase II clinical trials in China involving more than 700 participants


Manoj Sharma
November 17, 2020
Dr Ali Nouri, molecular biologist and President, Federation of American Scientists, has explained how these vaccine candidates work in simplest possible way on Twitter


PTI
November 10, 2020
They reported the design of a 'heat-tolerant' COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines


PTI
November 10, 2020
The coronavirus death toll climbed to 1,27,059 with 448 new fatalities, the data updated at 8 am showed


BusinessToday.In
November 10, 2020
Coronavirus vaccine: BioNTech Chief Executive Ugur Sahin, 55, son of Turkish immigrants who worked at the Ford factory in Cologne is now one of the 100 richest Germans, along with wife and board member Oezlem Tuereci, 53


BusinessToday.In
November 9, 2020
Researchers made their discovery while developing highly sensitive antibody tests for COVID-19. They compared the blood of COVID-19 patients with that of patients who had not had the disease


PTI
November 8, 2020
The total coronavirus cases mounted to 85,07,754 with  45,674  infections being reported in a day, while the death toll climbed to 1,26,121 with 559 new fatalities, the data updated at 8 am showed


PTI
November 7, 2020
Scientists have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target the COVID-19


BusinessToday.In
November 6, 2020
Denmark will cull as many as 1.7 crore minks after a mutated form of coronavirus was found on the animal's farms. Denmark's PM said the mutated virus posed a \"risk to the effectiveness\" of a future COVID-19 vaccine.


BusinessToday.In
November 4, 2020
Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials


BusinessToday.In
November 3, 2020
Air India said, 'All our passengers to Wuhan boarded the flight from Delhi with negative Covid reports from certified labs'. The airline added it strictly follows all safety protocols laid down by the regulatory body


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


BusinessToday.In
New Delhi, October 30, 2020
A person infected from novel coronavirus has a major chance of getting re-infected in just a few months or a year, a new UK-based study has claimed. As per the latest report by Imperial College London, the antibodies against COVID-19 wanes over time, which indicates that any level of immunity could last only a few months. The major decline in immunity included people aged 75 and above. The decline in antibodies was also seen in asymptomatic people or people who didn't report a history of COVID-19. Watch the video for more.


BusinessToday.In
New Delhi, October 29, 2020
Oxford and AstraZeneca's COVID-19 vaccine trials in India are expected to be over by January, said Serum Institute of India (SII) CEO Adar Poonawalla. Sharing details of the final stage of the trial, Poonawalla said that his company had already given the first dose to more than 1,000 patients. He added that the vaccine is producing a good immune response in addition to antibodies and would be up to the UK and Indian health authorities to take a decision on how safe and effective it is. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's aims to wind up Phase-3 trials of Sputnik V by March 2021


Vivek Punj
New Delhi, October 29, 2020
DGCA suspends international passenger flights till November 30India's aviation regulator on Wednesday extended the suspension of international passenger flights till November 30 due to coronavirus pandemic. The Directorate General of Civil Aviation (DGCA) added that the international scheduled flights may be allowed on certain routes by the competent authority on a case-to-case basis.Uber to offer 12,000 free rides to blind, low vision persons in 8 Indian citiesCab aggregator Uber has part...


Vivek Punj
New Delhi, October 28, 2020
Govt extends Unlock 5.0 guidelines till November 30The Unlock 5 guidelines issued by the Ministry of Home Affairs (MHA) on September 30 will remain in force up to November 30, the government said on Tuesday. The lockdown, however, will continue to be implemented strictly in the containment zones till November 30, 2020, it said.Hero MotoCorp to sell, develop Harley-Davidson bikes in India; deal signedHarley-Davidson and Hero MotoCorp on Tuesday announced that the two are entering into a par...


BusinessToday.In
October 28, 2020
The decline was largest in people aged 75 and above compared to younger people. Additionally, the decline in antibodies was also seen in asymptomatic people or people who didn't report a history of COVID-19


Reuters
October 28, 2020
British government is working on the assumption that the second wave of coronavirus will be more deadly than the first


PAGES 1 OF 10  12345